Vous n'êtes pas identifié (connexion)

Centre de recherche

BOTTIN

Éric Vigneault

Formation
à venir

Aucune offre active

Autres opportunités de carrière
Axe principal
Oncologie
Adresse(s)
Hôtel-Dieu de Québec
11, Côte du Palais, Bureau 3336
Québec (Québec)
CANADA G1R 2J6

Téléphone(s)
+1 418-691-5264
Télécopieur(s)
Courriel(s)
Eric.Vigneault@mail.chudequebec.ca

Projet(s) de recherche reconnu(s) par l'Université Laval

Autre(s) projet(s) de recherche actif(s)

Aucun projet de recherche à afficher

Publications récentes (voir toutes les publications de ce chercheur)

Beaulieu L, Racine E, Han DY, Vigneault E, Hsu IC, Cunha JAM. Real-time electromagnetic tracking-based treatment platform for high-dose-rate prostate brachytherapy: Clinical workflows and end-to-end validation. Brachytherapy,  2017. Epub
Miksys N, Vigneault E, Martin AG, Beaulieu L, Thomson RM. Large-scale Retrospective Monte Carlo Dosimetric Study for Permanent Implant Prostate Brachytherapy. International journal of radiation oncology, biology, physics ,  2017. 97: 606-615
Miksys N, Haidari M, Vigneault E, Martin AG, Beaulieu L, Thomson RM. Coupling I-125 permanent implant prostate brachytherapy Monte Carlo dose calculations with radiobiological models. Medical physics,  2017. Epub
Loblaw A, Pickles T, Crook J, Martin AG, Vigneault E, Souhami L, Cury F, Morris J, Catton C, Lukka H, Cheung P, Sethukavalan P, Warner A, Yang Y, Rodrigues G, Genitourinary Radiation Oncologists of Canada (GUROC). Stereotactic Ablative Radiotherapy Versus Low Dose Rate Brachytherapy or External Beam Radiotherapy: Propensity Score Matched Analyses of Canadian Data. Clinical oncology (Royal College of Radiologists (Great Britain)),  2017. 29: 161-170
Lalani N, Cummings B, Halperin R, Rakovitch E, Brundage M, Vigneault E, Milosevic M. The Practice of Radiation Oncology in Canada. International journal of radiation oncology, biology, physics ,  2017. 97: 876-880
Gaudet M, Vigneault E, Foster W, Meyer F, Martin AG. Randomized non-inferiority trial of Bicalutamide and Dutasteride versus LHRH agonists for prostate volume reduction prior to I-125 permanent implant brachytherapy for prostate cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,  2016. 118: 141-7
Vigneault E, Mbodji K, Beaudet ME, Despres P, Lavallee MC, Martin AG, Foster W, Aubin S, Beaulieu L. Does prostate volume has an impact on biochemical failure in patients with localized prostate cancer treated with HDR boost? Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,  2016. Epub
Zimmermann M, Taussky D, Menkarios C, Vigneault E, Beauchemin MC, Bahary JP, Martin AA, Diaz de Bedoya LV, Lambert C. Prospective Phase II Trial of Once-weekly Hypofractionated Radiation Therapy for Low-risk Adenocarcinoma of the Prostate: Late Toxicities and Outcomes. Clinical oncology (Royal College of Radiologists (Great Britain)),  2016. 28: 386-92
Azad AK, Bairati I, Qiu X, Girgis H, Cheng L, Waggott D, Cheng D, Mirshams M, Ho J, Fortin A, Vigneault E, Huang SH, O'Sullivan B, Waldron J, Boutros PC, Goldstein D, Meyer F, Xu W, Liu G. A genome-wide association study of non-HPV-related head and neck squamous cell carcinoma identifies prognostic genetic sequence variants in the MAP-kinase and hormone pathways. Cancer epidemiology,  2016. 42: 173-80
Vigneault E, Mbodji K, Racine LG, Chevrette E, Lavallee MC, Martin AG, Despres P, Beaulieu L. Image-Guided High-Dose-Rate (HDR) Boost Localization Using MRI/MR Spectroscopy: A Correlation Study with Biopsy. Cureus,  2016. Epub
© 2017 Tous droits réservés Centre de recherche du CHU de Québec